StoneX Group’s AEON Biopharma AEON Stock Holding History

StoneX Group’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,578	Closed	-$14.2K	–	1090
2025 Q3	$14.2K	Buy	+17,578	New	+$13.5K	﹤0.01%	892

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

LNWTC

Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

StoneX Group's AEON Position: Q4 2025 in Review

StoneX Group sold out of AEON Biopharma (AEON) in Q4 2025, closing a stake of 17,578 shares — an estimated $14.2K sold.

StoneX Group first reported a position in AEON in Q3 2025 and held it in 1 quarter. The position peaked at $14.2K in Q3 2025. 22 funds tracked by Wall St. Rank hold AEON as of Q4 2025.

StoneX Group reported no remaining AEON Biopharma position as of Q4 2025 after selling out during the quarter.
StoneX Group sold 17,578 AEON Biopharma shares in Q4 2025, an estimated $14.2K.
StoneX Group first reported a position in AEON Biopharma in Q3 2025 and held it in 1 quarter.
StoneX Group's AEON Biopharma position peaked at $14.2K in Q3 2025.
22 funds tracked by Wall St. Rank held AEON Biopharma as of Q4 2025.

Based on StoneX Group's 13F filing for Q4 2025, filed 12 Feb 2026.